Our company provides extensive GMP-grade peptide synthesis and manufacturing services to partners worldwide. We specialize in the production of peptides of varying lengths and complexities, utilizing state-of-the-art technologies. Our skilled team ensures stringent quality control throughout every stage of the process, from planning to distribution

Viking Therapeutics has formed a mutually beneficial alliance with U.S. biopharmaceutical companies to develop and manufacture its GLP-1 drug candidate, VK2735. This marks a significant advancement in securing dependable production capabilities for these vital therapeutic agents. The agreement enables them to handle large-scale peptide manufacturin